Search

Your search keyword '"Rheumatoid arthritis -- Health aspects"' showing total 71 results
Start Over Descriptor "Rheumatoid arthritis -- Health aspects" Language english
71 results on '"Rheumatoid arthritis -- Health aspects"'

1. Nontuberculous mycobacteria infections and anti-tumor necrosis factor-[alpha] therapy

Author

Winthrop, Kevin L., Chang, Eric, Yamashita, Shellie, Iademarco, Michael F., and LoBue, Philip A.

Subjects
Infection -- Health aspects, Rheumatoid arthritis -- Health aspects, Tumors -- Health aspects, Tumor necrosis factor -- Health aspects, Tuberculosis -- Health aspects, Antirheumatic agents -- Health aspects, Corticosteroids -- Health aspects, Rheumatoid factor -- Health aspects, Necrosis -- Health aspects
Abstract

Nontuberculous mycobacteria (NTM) are a large, diverse group of environmental organisms ubiquitous in water and soil (1). They cause a variety of diseases in humans, notably severe, protracted lung disease [...]

Published
2009
Full Text
View/download PDF

2. Unmet needs of patients with systemic lupus erythematosus

Author

Danoff-Burg, Sharon and Friedberg, Fred

Subjects
Systemic lupus erythematosus -- Research, Systemic lupus erythematosus -- Care and treatment, Rheumatoid arthritis -- Care and treatment, Rheumatoid arthritis -- Health aspects, Patient satisfaction -- Research, Health, Psychology and mental health
Abstract

The authors' goal was to assess unmet needs of patients with systemic lupus erythematosus (SLE). Participants (N = 112), who were recruited through the mailing list and support group meetings of a Lupus Alliance of America Affiliate, completed a survey based on prior research. All participants perceived at least 1 unmet need. The most frequently reported unmet needs were in the physical symptoms domain. Older patients were more likely than younger patients to have higher levels of unmet needs related to physical and psychological functioning. African American patients were more likely than white patients to have higher levels of unmet needs related to health services and information. Our findings document the high prevalence and variety of unmet needs among these patients, as well as variations among demographic groups. To address unmet needs of SLE patients, targeted referrals to patient educators, mental health professionals, and support organizations are important adjuncts to medical treatment. Index Terms: needs assessment, patient satisfaction, systemic lupus erythematosus, unmet needs, Qualitative studies have revealed that patients with chronic illnesses, including systemic lupus erythematosus (SLE), often report withholding the full range of their needs from health care providers.(1-3) Ascertaining the perceived [...]

Published
2009

3. Experienced health in older women with rheumatoid arthritis

Author

Lyyra, Tiina-Mari and Heikkinen, Riitta-Liisa

Subjects
Rheumatoid arthritis -- Health aspects, Rheumatoid arthritis -- Care and treatment, Middle aged women -- Health aspects, Women -- Health aspects, Women -- Analysis, Seniors, Women's issues/gender studies
Abstract

This study explored how older women with chronic illness and disability experience their own health. Data were collected in in-depth interviews with ten older women with rheumatoid arthritis. Data analysis and interpretation was carried out within a phenomenological-hermcneutic fiame of understanding, which revealed five major themes: health as coping with everyday life, health as freedom, health as absence of inconvenience, health as togetherness and health as mental well-being. For older people with chronic illness and disability, good health found expression in general well-being. It was perceived as a state of equilibrium that the respondents sought to maintain through their own active choices. doi: 10.1300/J074v18n04_06 KEYWORDS. Self-rated health, health experiences, disability, chronic illness, ageing, rheumatoid arthritis, health equilibrium

Published
2006

5. Biopharmaceuticals: approval trends in 2007: fifteen biopharmaceuticals gained approval in the US or EU in 2007, a though only 9 of them were new approvals

Author

Walsh, Gary

Subjects
Biopharmaceutics -- Health aspects, Anemia -- Health aspects, Rheumatoid factor -- Health aspects, Antiarthritic agents -- Health aspects, Erythropoietin -- Health aspects, Amino acids -- Health aspects, Rheumatoid arthritis -- Health aspects, Growth factors -- Health aspects
Abstract

The year 2007 witnessed the approval of 15 biopharmaceuticals in the United States and/or European Union (EU). The 15 approvals included six erythropoietin (EPO)-based products, three antibodies, and two hormones, [...]

Published
2008

6. Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study

Author

Karvounaris, S.A., Sidiropoulos, P.I., Papadakis, J.A., Spanakis, E.K., Bertsias, G.K., Kritikos, H.D., Ganotakis, E.S., and Boumpas, D.T.

Subjects
Rheumatoid arthritis -- Research, Rheumatoid arthritis -- Health aspects, Rheumatoid arthritis -- Demographic aspects, Cardiovascular diseases -- Risk factors, Cardiovascular diseases -- Research, Health
Published
2007

7. COX-2 selective inhibitors and heart health

Author

Simon, Lee S. and White, William B.

Subjects
Coronary artery bypass -- Health aspects, Angiogenesis inhibitors -- Health aspects, Prostaglandins -- Health aspects, Blood pressure -- Health aspects, Nonsteroidal anti-inflammatory drugs -- Health aspects, Analgesics -- Health aspects, Drugs -- Health aspects, Cardiac patients -- Care and treatment, Cardiac patients -- Health aspects, Osteoarthritis -- Risk factors, Osteoarthritis -- Prevention, Osteoarthritis -- Care and treatment, Osteoarthritis -- Health aspects, Rheumatoid factor -- Health aspects, Rheumatoid arthritis -- Risk factors, Rheumatoid arthritis -- Prevention, Rheumatoid arthritis -- Care and treatment, Rheumatoid arthritis -- Health aspects, Rofecoxib -- Health aspects, COX-2 inhibitors -- Health aspects, Hypertension -- Risk factors, Hypertension -- Prevention, Hypertension -- Care and treatment, Hypertension -- Health aspects, Heart attack -- Risk factors, Heart attack -- Prevention, Heart attack -- Care and treatment, Heart attack -- Health aspects, Congestive heart failure -- Risk factors, Congestive heart failure -- Prevention, Congestive heart failure -- Care and treatment, Congestive heart failure -- Health aspects, Antihypertensive drugs -- Health aspects, Pain -- Care and treatment, Pain -- Health aspects, Chemical inhibitors -- Health aspects, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Medicare -- Health aspects, Stroke (Disease) -- Risk factors, Stroke (Disease) -- Prevention, Stroke (Disease) -- Care and treatment, Stroke (Disease) -- Health aspects, Health
Published
2005

8. Long term efficacy and safety of cyclosporin versus parenteral gold in early rheumatoid arthritis: a three year study of radiographic progression, renal function, and arterial hypertension. (Extended Report)

Author

Kvien, TK, Zeidler, HK, Hannonen, P, Wollheim, FA, Forre, O, Hafstrom, I, Kaltwasser, JP, Leirisalo-Repo, M, Manger, B, Laasonen, L, Prestele, H, and Kurki, P

Subjects
Gold -- Health aspects -- Evaluation, Cyclosporine -- Evaluation, Rheumatoid arthritis -- Health aspects, Health, Evaluation, Health aspects
Abstract

Objective: To compare the three year safety and efficacy of cyclosporin and parenteral gold in the treatment of early, active, severe rheumatoid arthritis (RA), and to study the reversibility of [...]

Published
2002

9. The ICIDH-2 as a framework for the assessment of functioning and disability in rheumatoid arthritis. (Extended Report)

Author

Fransen, J, Uebelhart, D, Stucki, G, Langenegger, T, and Seitz, M

Subjects
Health status indicators -- Evaluation -- Health aspects, Rheumatoid arthritis -- Health aspects, Health, Evaluation, Health aspects
Abstract

Objective: To investigate by a cross sectional study in patients with rheumatoid arthritis (RA) the relationship between measures of impairment, activity limitation, and participation of the model of functioning and [...]

Published
2002

10. Drug May Delay MS Disability for Some

Subjects
Multiple sclerosis -- Research, Rituximab -- Research, Rheumatoid arthritis -- Health aspects, Health
Abstract

Byline: Serena Gordon, HealthDay ReporterWEDNESDAY, Jan. 9, 2019 (HealthDay News) -- An immune system drug may help prevent or slow complications in a type of multiple sclerosis known as secondary [...]

Published
2019

11. An episodic eruption. (Rash)

Author

Bentley, P. and Keat, A.

Subjects
Skin diseases -- Evaluation -- Health aspects, Sjogren's syndrome -- Health aspects, Rheumatoid arthritis -- Health aspects, Health, Evaluation, Health aspects
Abstract

A 72 year old woman presented with a fleeting rash, lasting several days at a time, on both thighs and lower trunk, over a four month period (fig 1). The [...]

Published
2002

12. Disease activity scores in RA differ with pain perception and sex

Subjects
Pain -- Evaluation -- Health aspects, Rheumatoid arthritis -- Health aspects, Health
Abstract

Leeb BF, Haindl PM, Maktari A, et al, Lower Austrian Center for Rheumatology, Stockerau, Austria, and other centers. Disease activity score-28 values differ considerably depending on patient's pain perception and [...]

Published
2008

13. Ultrasounds spot heart disease early in rheumatoid arthritis patients, Mayo Clinic finds

Subjects
Heart diseases -- Health aspects, Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Health, Rheumatoid factor -- Health aspects, Arthritis -- Health aspects, Cardiovascular diseases -- Health aspects, Physical fitness -- Health aspects, Rheumatoid arthritis -- Health aspects, Health
Abstract

By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- ROCHESTER, Minn. - Special echocardiograms show promise for early detection of a potentially deadly complication in rheumatoid [...]

Published
2012

14. Assessing physical activity in persons with rheumatoid arthritis using accelerometry

Author

Semanik, Pamela, Song, Jing, Chang, Rowland W., Manheim, Larry, Ainsworth, Barbara, and Dunlop, Dorothy

Subjects
Rheumatoid arthritis -- Health aspects, Accelerometers -- Usage, Exercise -- Health aspects, Health, Sports and fitness
Abstract

The study investigates if the non-wear threshold and the 'valid day' definition for accelerometer data from the general adult U.S. population are appropriate for accelerometer data from persons with rheumatoid arthritis (RA). Evidence supports increasing the allowed non-wear threshold in the RA sub-population from 60 to 90 minutes, while retaining the 10-hour day as the 'valid day' measure.

Published
2010

15. Depression and chronic medical illness: why psychiatrists should care

Author

Sachdeva, Shilpa

Subjects
Antiparkinsonian agents -- Health aspects, Antiparkinsonian agents -- Social aspects, Biological response modifiers -- Health aspects, Biological response modifiers -- Social aspects, Cancer patients -- Care and treatment, Cancer patients -- Social aspects, Cancer patients -- Health aspects, Palliative treatment -- Health aspects, Palliative treatment -- Social aspects, Rheumatoid arthritis -- Development and progression, Rheumatoid arthritis -- Care and treatment, Rheumatoid arthritis -- Risk factors, Rheumatoid arthritis -- Health aspects, Rheumatoid arthritis -- Social aspects, Oncology, Experimental -- Development and progression, Oncology, Experimental -- Health aspects, Oncology, Experimental -- Social aspects, Stroke (Disease) -- Development and progression, Stroke (Disease) -- Care and treatment, Stroke (Disease) -- Risk factors, Stroke (Disease) -- Health aspects, Stroke (Disease) -- Social aspects, Psychiatrists -- Social aspects, Psychiatrists -- Health aspects, Antihypertensive drugs -- Health aspects, Antihypertensive drugs -- Social aspects, Congestive heart failure -- Development and progression, Congestive heart failure -- Care and treatment, Congestive heart failure -- Risk factors, Congestive heart failure -- Health aspects, Congestive heart failure -- Social aspects, Hypertension -- Development and progression, Hypertension -- Care and treatment, Hypertension -- Risk factors, Hypertension -- Health aspects, Hypertension -- Social aspects, Cardiac patients -- Care and treatment, Cardiac patients -- Social aspects, Cardiac patients -- Health aspects, Serotonin uptake inhibitors -- Health aspects, Serotonin uptake inhibitors -- Social aspects, Medical care, Cost of -- Health aspects, Medical care, Cost of -- Social aspects, Anxiety -- Development and progression, Anxiety -- Care and treatment, Anxiety -- Risk factors, Anxiety -- Health aspects, Anxiety -- Social aspects, Rheumatoid factor -- Health aspects, Rheumatoid factor -- Social aspects, Cancer -- Research, Cancer -- Development and progression, Cancer -- Health aspects, Cancer -- Social aspects, Pain -- Care and treatment, Pain -- Health aspects, Pain -- Social aspects, Health, Health care industry, Psychology and mental health
Abstract

Issue Depression is one of the most prevalent psychiatric disorders and when co-occurring with medical illnesses likely creates a vicious circle in which each separate ailment makes treatment outcomes worse [...]

Published
2009

16. TNF inhibitor cancer risk doubt

Subjects
Rheumatoid arthritis -- Risk factors, Rheumatoid arthritis -- Health aspects, Oncology, Experimental -- Health aspects, Cancer -- Risk factors, Cancer -- Health aspects, Cancer -- Research, Business, Business, international, Health care industry
Published
2006

17. Diagnosing Crohn's disease in patients with arthritis

Author

Reimold, A.

Subjects
Rheumatoid arthritis -- Health aspects, Crohn's disease -- Diagnosis
Abstract

Byline: A. Reimold The arthritis associated with Crohn's disease occurs in up to 26% of those diagnosed with the gut disorder.[1] The inflammatory peripheral arthritis classically involves the knees and [...]

Published
2005

18. A good night's sleep is ]

Subjects
Sleep disorders -- Care and treatment, Valeriana -- Health aspects, Valeriana -- Complications and side effects, Rheumatoid arthritis -- Health aspects
Abstract

A good night's sleep is a dream for most people with rheumatoid arthritis (RA). Two-thirds report fatigue, and research suggests that drugs inhibit slow-wave sleep, which RA sufferers need. In [...]

Published
2005

19. Eye on Amgen

Author

Barclay, Laurie

Subjects
Rheumatoid factor -- Health aspects, Biotechnology industry -- Product development -- Health aspects, Antirheumatic agents -- Product development -- Health aspects, Cancer -- Care and treatment, Kidney diseases -- Health aspects, Rheumatoid arthritis -- Health aspects, Pharmaceutical industry -- Product development -- Health aspects, Health, Vectibix (Medication) -- Health aspects
Abstract

Amgen is a pioneering biotechnology company in human therapeutics, with more than 25 years of experience applying scientific breakthroughs to the development of new biologic agents. Utilizing advances in recombinant [...]

Published
2011

20. Labour force participation among patients with rheumatoid arthritis

Author

Chorus, Astrid M J, Miedema, Harald S., Wevers, Cees J., and van der Linden, Sjef

Subjects
Patients -- Employment, Rheumatoid arthritis -- Health aspects, Health, Employment, Health aspects
Abstract

Abstract Objectives--To assess work history and labour force participation among patients with rheumatoid arthritis (RA) in the Netherlands. Methods--A random sample of 1056 patients with RA aged 16-59 years from [...]

Published
2000

21. Complementary & alternative medicine for women

Subjects
Rheumatoid factor -- Health aspects, Rheumatoid arthritis -- Health aspects, Women -- Health aspects, Antiarthritic agents -- Health aspects, Alternative medicine -- Health aspects, Cancer -- Care and treatment, Cancer -- Health aspects
Abstract

It was bad enough when Jennifer Tilofi* was diagnosed with rheumatoid arthritis six years ago at age 31; but when, after nearly four years of treatment with some pretty toxic […]

Published
2007

22. Event Brief of Q3 2008 Roche Holding AG Sales Conference Call - Final

Subjects
Morgan Stanley -- Product introduction, Roche Holding AG -- Product introduction, Societe Generale S.A. -- Product introduction, Biological products industry -- Product introduction -- Health aspects, Rheumatoid factor -- Health aspects, Diabetes -- Health aspects, Banking industry -- Health aspects -- Product introduction, Erosion -- Health aspects, Customer relations -- Health aspects, Competition (Economics) -- Health aspects, Growth factors -- Health aspects, Pharmaceutical industry -- Product introduction -- Health aspects, Metastasis -- Health aspects, Stomach cancer -- Health aspects, Angiogenesis inhibitors -- Health aspects, Monoclonal antibodies -- Health aspects, Rheumatoid arthritis -- Health aspects, Workflow software, Banking industry, Business, Rituxan (Medication) -- Product introduction -- Health aspects, Tarceva (Medication) -- Product introduction -- Health aspects, Herceptin (Medication) -- Product introduction -- Health aspects, Avastin (Medication) -- Product introduction -- Health aspects
Abstract

PARTICIPANTS . Severin Schwan, Roche Holdings AG, CEO . Bill Burns, Roche Pharmaceuticals, CEO . Juergen Schwiezer, Roche Diagnostics, CEO . Erich Hunziker, Roche Group, CFO . Sachin Jain, Merrill [...]

Published
2008

23. Rheumatoid arthritis drug may increase cancer risk

Subjects
Oncology, Experimental -- Drug therapy, Oncology, Experimental -- Reports, Oncology, Experimental -- Health aspects, Cancer -- Risk factors, Cancer -- Drug therapy, Cancer -- Reports, Cancer -- Health aspects, Rheumatoid arthritis -- Risk factors, Rheumatoid arthritis -- Drug therapy, Rheumatoid arthritis -- Reports, Rheumatoid arthritis -- Health aspects, Methotrexate -- Reports, Methotrexate -- Health aspects, Rheumatoid factor -- Reports, Rheumatoid factor -- Health aspects, Cancer -- Research, Cancer -- Care and treatment, General interest, News, opinion and commentary
Abstract

Sufferers of rheumatoid arthritis who take the antirheumatic drug methotrexate increase their risk of developing certain types of cancer, suggests new research. Rheumatoid arthritis is a chronic inflammatory illness that [...]

Published
2008

24. Fibromyalgia and Hepatitis C: Is There an Association?

Subjects
Rheumatoid factor -- Health aspects, Rheumatoid arthritis -- Health aspects, Infection -- Health aspects, Fibromyalgia -- Health aspects, Hepatitis C -- Health aspects, Associations, institutions, etc. -- Health aspects, Societies -- Health aspects, Health
Abstract

Fibromyalgia and Hepatitis C: Is There an Association? ABSTRACT & COMMENTARY Synopsis: Serologic evidence of hepatitis C infection was reported to be more than six times more prevalent in patients [...]

Published
1998

25. Gearing Up for Summer While Living with Moderate to Severe Rheumatoid Arthritis (RA)

Subjects
Rheumatoid arthritis -- Health aspects, Rheumatoid factor -- Health aspects, Arthritis -- Health aspects, News, opinion and commentary, Sports and fitness, Orencia (Medication) -- Health aspects
Abstract

June 5, 2015 Filed under Health & Wellness - Following a long, cold winter that saw heavy snowfall and low temperatures around the country, Americans are finally thawing out and [...]

Published
2015

26. Biologics slightly increase risk of skin cancer; TNF-blockers don't increase risk of other cancers

Subjects
Rheumatoid arthritis -- Care and treatment, Rheumatoid arthritis -- Risk factors, Rheumatoid arthritis -- Health aspects, Skin cancer -- Care and treatment, Skin cancer -- Risk factors, Skin cancer -- Health aspects, Antirheumatic agents -- Health aspects, Oncology, Experimental -- Health aspects, Cancer -- Care and treatment, Cancer -- Health aspects, Cancer -- Research, Health
Abstract

Use of biologic drugs known as tumor necrosis factor-alpha blockers including Enbrel (etanercept), Remicade (infliximab) and Humira (adalimumab) have revolutionized the treatment of rheumatoid arthritis (RA). But these drugs do [...]

Published
2007

27. New Treatments Emerging from Immune and Inflammatory Disease R&D Pipelines

Subjects
United States. Centers for Disease Control and Prevention, Pfizer Inc., Rheumatoid arthritis -- Health aspects, Pharmaceutical industry -- Health aspects, Business, general, Arthritis Foundation
Abstract

New York, NY (PRWEB) June 19, 2012 A new syndicated TrendsmemeTM Report: Immune and Inflammatory Diseases has been released by Medmeme, LLC., a global leader in comprehensive, integrated medical and [...]

Published
2012

28. Abbott to present wide range of investigational efficacy, safety and health outcomes data on Humira (adalimumab) at the Annual Meeting of the European League Against Rheumatism

Subjects
Rheumatoid arthritis -- Health aspects, Business, Chemicals, plastics and rubber industries, Humira (Medication) -- Health aspects
Abstract

Abbott scientists and independent researchers will highlight the latest investigational research findings on Humira (adalimumab) at the European League Against Rheumatism (EULAR) Congress in Berlin, Germany, from 6 Jun-9 Jun [...]

Published
2012

29. Alder Biopharmaceuticals to receive $15 M milestone payment from Bristol-Myers Squibb for initiation of Phase IIb clinical trial in rheumatoid arthritis of ALD518/BMS-945429 antibody therapeutic against IL-6

Subjects
Bristol-Myers Squibb Co. -- Product development, Biopharmaceutics -- Product development -- Health aspects, Rheumatoid factor -- Health aspects, Clinical trials -- Health aspects, Interleukins -- Product development -- Health aspects, Rheumatoid arthritis -- Health aspects, Pharmaceutical industry -- Product development -- Health aspects, Business, Chemicals, plastics and rubber industries
Abstract

Alder Biopharmaceuticals Inc announced it will receive a $15 M milestone payment from Bristol-Myers Squibb for the initiation of a Phase IIb clinical trial in rheumatoid arthritis for ALD518/BMS-945429, an [...]

Published
2011

30. Alder Biopharmaceuticals to Receive $15 Million Milestone Payment from Bristol-Myers Squibb for Initiation of Phase 2b Clinical Trial in Rheumatoid Arthritis of ALD518/BMS-945429 Antibody Therapeutic Against IL-6

Subjects
Bristol-Myers Squibb Co. -- Product development, Biopharmaceutics -- Product development -- Health aspects, Rheumatoid factor -- Health aspects, Clinical trials -- Health aspects, Interleukins -- Product development -- Health aspects, Rheumatoid arthritis -- Health aspects, Pharmaceutical industry -- Product development -- Health aspects, Business, News, opinion and commentary
Abstract

BOTHELL, Wash., June 20, 2011 /PRNewswire/ -- Alder Biopharmaceuticals Inc. today announced it will receive a $15 million milestone payment from Bristol-Myers Squibb for the initiation of a Phase 2b [...]

Published
2011

31. Compugen announces positive therapeutic effect of CGEN-15001 in animal model of rheumatoid arthritis

Subjects
Compugen Ltd., Rheumatoid factor -- Health aspects, Biotechnology industry -- Health aspects, Antirheumatic agents -- Health aspects, Rheumatoid arthritis -- Health aspects, Business, Chemicals, plastics and rubber industries
Abstract

Compugen Ltd announced that administration of CGEN-15001 in an animal model of rheumatoid arthritis (RA) dramatically ameliorates the clinical symptoms of the disease. These results, combined with earlier results in [...]

Published
2010

32. Biologic users mycobacterial lung infection

Author

Jancin, Bruce

Subjects
Lung diseases -- Health aspects, Respiratory tract diseases -- Health aspects, Rheumatoid factor -- Health aspects, Antirheumatic agents -- Health aspects, Tumor necrosis factor -- Health aspects, Rheumatoid arthritis -- Health aspects, Health, Health care industry
Abstract

SNOWMASS, COLO. - Rheumatoid arthritis patients on tumor necrosis factor inhibitors are at increased risk for tuberculosis and nontuberculous mycobacterial lung disease, data from Kaiser Permanente of Northern California show. [...]

Published
2012

33. Analyse Therapeutic Clinical Intelligence - Rheumatoid Arthritis

Subjects
Rheumatoid factor -- Health aspects, Biological products -- Market research -- Health aspects, Rheumatoid arthritis -- Health aspects, Marketing research, Business, Business, international
Abstract

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c78644) has announced the addition of 'Therapeutic Clinical Intelligence - Rheumatoid Arthritis' to their offering. The world-wide market for Rheumatoid Arthritis (RA) therapeutics has [...]

Published
2008

34. Rheumatoid arthritis ... Anesthesia ... Hammertoe

Author

Ferrell, Bruce A.

Subjects
Medical research -- Health aspects, Medicine, Experimental -- Health aspects, Rheumatoid factor -- Health aspects, Anesthesia -- Health aspects, Rheumatoid arthritis -- Health aspects, Atherosclerosis -- Health aspects, Health
Abstract

Q I recently read that people with rheumatoid arthritis are at a higher risk for cardiovascular disease than those without arthritis. Why would that be? A Rheumatoid arthritis (RA) is [...]

Published
2010

35. Think infection when lung issues strike in RA

Author

Jancin, Bruce

Subjects
Rheumatoid factor -- Health aspects, Infection -- Health aspects, Rheumatoid arthritis -- Health aspects, Health
Abstract

KEYSTONE, COLO. -- The top diagnostic priorities when a lung problem is detected in a patient with underlying rheumatoid arthritis or another autoimmune disease are to rule out infection and [...]

Published
2010

36. Chelsea Therapeutics Closes $21.5 Million Placement with Leading Biotech Investors; Proceeds Enable Phase II Proof of Concept Studies of CH-1504 in Rheumatoid Arthritis and Psoriasis and Expansion of Therapeutic Pipeline

Subjects
Biotechnology -- Health aspects, Rheumatoid arthritis -- Health aspects, Psoriasis -- Health aspects, Drugs -- Health aspects, Business, Business, international
Abstract

CHARLOTTE, N.C. -- Chelsea Therapeutics International, Ltd. (OTCBB: CHTP), completed a private placement of approximately 7.2 million shares of its common stock to institutional and other accredited investors, resulting in [...]

Published
2006

37. Anti-TNF agents may up skin cancer risk

Author

Napoli, Denise

Subjects
Rheumatoid arthritis -- Risk factors, Rheumatoid arthritis -- Care and treatment, Rheumatoid arthritis -- Health aspects, Oncology, Experimental -- Health aspects, Dermatologic agents -- Health aspects, Rheumatoid factor -- Health aspects, Cancer -- Research, Cancer -- Health aspects, Dermatology -- Formulae, receipts, prescriptions, Dermatology -- Health aspects, Cancer -- Care and treatment, Skin -- Care and treatment, Skin -- Health aspects, Health, Health care industry
Abstract

PHILADELPHIA -- Two studies showed an increased risk for non-melanoma skin cancer in patients who take anti-tumor necrosis factor therapies, and should prompt physicians to evaluate the use of these [...]

Published
2009

38. Vitamin D deficiency found prevalent in RA

Author

Zoler, Mitchel L.

Subjects
Rheumatoid arthritis -- Health aspects, Vitamin D deficiency -- Risk factors
Abstract

PHILADELPHIA -- Patients with moderately active rheumatoid arthritis had a high prevalence of vitamin D insufficiency and deficiency in a prospective study of 1,160 patients in the Veterans Health Administration [...]

Published
2009

39. Etanercept: histoplasmosis and invasive fungal infections

Subjects
Rheumatoid factor -- Health aspects, Rheumatoid arthritis -- Health aspects, Infection -- Health aspects, Histoplasmosis -- Health aspects, Etanercept -- Health aspects
Abstract

Canada -- The manufacturer of etanercept (Enbrel[R]) has informed healthcare professionals of the risk of invasive fungal infections, including histoplasmosis. Etanercept is indicated for the treatment of rheumatoid arthritis, psoriatic [...]

Published
2009

41. MRSA infections are seen in patients on anti-TNF therapy

Author

Walsh, Nancy

Subjects
Rheumatoid factor -- Health aspects, Rheumatoid arthritis -- Care and treatment, Rheumatoid arthritis -- Health aspects, Staphylococcal infections -- Care and treatment, Staphylococcal infections -- Health aspects, Infection -- Care and treatment, Infection -- Health aspects, Staphylococcus aureus -- Health aspects, Tumor necrosis factor -- Health aspects
Abstract

PARIS -- Methicillin-resistant Staphylococcus aureus infections have been reported for the first time in patients with rheumatoid arthritis being treated with tumor necrosis factor inhibitors. In a poster presented at [...]

Published
2008

42. Serious infections with biologics stress need for extra vigilance

Author

Walsh, Nancy

Subjects
Rheumatoid arthritis -- Care and treatment, Rheumatoid arthritis -- Health aspects, Methotrexate -- Health aspects, Prednisone -- Health aspects, Leflunomide -- Health aspects, Sulfonamides -- Health aspects, Corticosteroids -- Health aspects, Rheumatoid factor -- Health aspects, Infection -- Care and treatment, Infection -- Health aspects, Health, Health care industry
Abstract

LIVERPOOL, ENGLAND -- Serious and even fatal infections continue to occur in patients being treated with tumor necrosis factor-blocking agents and other biologics, emphasizing the need for heightened vigilance during [...]

Published
2008

43. Use of TNF blockers may raise skin cancer risk

Author

Walsh, Nancy

Subjects
Rheumatoid factor -- Health aspects, Rheumatoid arthritis -- Care and treatment, Rheumatoid arthritis -- Risk factors, Rheumatoid arthritis -- Health aspects, Antirheumatic agents -- Health aspects, Tumor necrosis factor -- Health aspects, Health, Health care industry, New York University
Abstract

NEW YORK -- The greatest malignancy risk in patients receiving tumor necrosis factor antagonists is skin cancer, Dr. Jeffrey Greenberg said at a rheumatology meeting sponsored by New York University. [...]

Published
2008

44. Heart failure deemed driving force in excess mortality in RA

Author

Jancin, Bruce

Subjects
Rheumatoid factor -- Health aspects, Rheumatoid arthritis -- Health aspects, Heart failure -- Health aspects, Mortality
Abstract

SNOWMASS, COLO. -- Heart failure is a major contributor to the excess mortality in patients with rheumatoid arthritis, Dr. Sherine E. Gabriel said at a symposium sponsored by the American [...]

Published
2008

45. Subtle heart failure signs increase RA mortality risk

Author

Mahoney, Diana

Subjects
Rheumatoid factor -- Health aspects, Rheumatoid arthritis -- Health aspects, Heart failure -- Health aspects, Mortality
Abstract

BOSTON -- Heart failure appears to be treated less aggressively in people with concomitant rheumatoid arthritis, based on the results of a community-based cohort study. The findings, which were reported [...]

Published
2008

46. Life expectancy no better in RA patients, despite new therapies

Author

Napoli, Denise

Subjects
Rheumatoid factor -- Health aspects, Rheumatoid arthritis -- Care and treatment, Rheumatoid arthritis -- Health aspects
Abstract

Rheumatoid arthritis patients have not experienced a decline in mortality, despite dramatically increased life expectancy in the general population and newer, more aggressive arthritis treatments. This stagnation is contributing to [...]

Published
2008

47. High RA disease activity is tied to greater risk of infection

Author

Walsh, Nancy

Subjects
Rheumatoid factor -- Health aspects, Rheumatoid arthritis -- Risk factors, Rheumatoid arthritis -- Health aspects, Infection -- Risk factors, Infection -- Health aspects, Antirheumatic agents -- Health aspects, Medical research -- Health aspects, Medicine, Experimental -- Health aspects
Abstract

BOSTON -- Increased rheumatoid arthritis disease activity is associated with a greater risk of developing infections, judging from the analysis of data from a large rheumatology database, Dr. Daniel E. [...]

Published
2008

48. TNF inhibitors improve mortality in rheumatoid arthritis

Author

Walsh, Nancy

Subjects
Methotrexate -- Health aspects, Rheumatoid arthritis -- Health aspects, Cytokines -- Health aspects, Mortality
Abstract

BARCELONA -- Treatment with tumor necrosis factor blocking drugs has been shown for the first time to improve mortality in rheumatoid arthritis, Dr. Lennart Jacobsson said at the annual European [...]

Published
2007

Catalog

Books, media, physical & digital resources
See catalog results